Medical Responsible [clinicaltrials_resource:a1a82f850f59c6347b5c6afc5a6a7283]
A Multicenter Trial of AS902330 (Recombinant Human Fibroblast Growth Factor-18) or Placebo After Microfracture Surgery for Cartilage Injury of the Knee [clinicaltrials:NCT01689337]clinicaltrials:NCT01972568MSB0010445 and Stereotactic Body Radiation Therapy in Advanced Melanoma [clinicaltrials:NCT01973608]Relative Bioavailability of Pimasertib in Cancer Patients [clinicaltrials:NCT01992874]Rebif® Rebidose® Versus Rebiject II® Ease-of-Use [clinicaltrials:NCT02019550]clinicaltrials:NCT02047500clinicaltrials:NCT02070978
overall official [clinicaltrials_vocabulary:overall-official]
Medical Responsible [clinicaltrials_resource:a1a82f850f59c6347b5c6afc5a6a7283]
Bio2RDF identifier
a1a82f850f59c6347b5c6afc5a6a7283
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:a1a82f850f59c6347b5c6afc5a6a7283
affiliation [clinicaltrials_vocabulary:affiliation]
email [clinicaltrials_vocabulary:email]
service@merckgroup.com
last name [clinicaltrials_vocabulary:last-name]
Medical Responsible
phone [clinicaltrials_vocabulary:phone]
888-275-7376
role [clinicaltrials_vocabulary:role]
Study Director
identifier
clinicaltrials_resource:a1a82f850f59c6347b5c6afc5a6a7283
title
Medical Responsible
@en
type
label
Medical Responsible [clinicaltrials_resource:a1a82f850f59c6347b5c6afc5a6a7283]
@en